PMCID,Source,Database,Query,Regular_Expression,Match,Manual_Verification,SMILES,Drug_Name,Class
400409,https://doi.org/10.1186/ar1014,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Opioid peptides unable to cross the blood-brain barrier are the natural ligands for opioid receptors,Fail,-,,
1933540,https://doi.org/10.1186/1748-717X-2-23,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," By choosing boron-compounds which are unable to cross the blood-brain barrier, a largely selective irradiation of the vessel walls can be accomplished with BNCT",Fail,-,,
2376090,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376090/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Two prokinetic drugs, that are commonly used in gastrointestinal disorders, induce hyperprolactinemia via a dopamine-antagonistic mechanism (Figure 2): metoclopramide, that blocks dopamine and, at higher doses, also serotonin receptors in chemoreceptor trigger zone of CNS, and domperidone, that does not cross the blood brain barrier and is therefore a selective peripheral (extra cerebral) dopamine antagonist",Duplicate,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,domperidone,0
2500042,https://doi.org/10.1186/1471-2377-8-27,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Etanercept does not cross the blood-brain barrier when administered systemically [59],Duplicate,-,Etanercept,0
2700615,https://doi.org/10.4103/0974-2700.43190,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"2 mg can be given before neostigmine as, unlike atropine, glycopyrrolate does not cross the blood–brain barrier",Duplicate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],glycopyrrolate,0
2700618,https://doi.org/10.4103/0974-2700.43180,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"[13] Since atropine may produce serious central nervous system toxicity, the use of glycopyrrolate which does not cross the blood-brain barrier has been studied",Pass,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],glycopyrrolate,0
2737114,https://doi.org/10.1007/s11095-009-9939-6,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," The neurotrophin must be administered to brain via a trans-cranial route, because GDNF does not cross the blood-brain barrier (BBB) (5)",Duplicate,-,GDNF,0
2738400,https://doi.org/10.4103/0019-5545.44900,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,Etanercept needs to be administered by perispinal injection because it is a large molecule which does not cross the blood-brain barrier,Duplicate,-,Etanercept,0
2769002,https://doi.org/10.2174/157015909789152128,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," However, until now the pharmacological administration of neurotrophic factors in vivo has not been easy because these molecules are unable to cross the blood brain barrier, making invasive application strategies like intracerebroventricular infusion necessary",Fail,-,,
2792620,https://doi.org/10.4103/0253-7613.44151,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, It does not cross the blood-brain barrier and is 30 times more selective for the a-2-adrenergic receptor than apraclonidine,Fail,-,,
2831839,https://doi.org/10.1186/2040-2384-2-5,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Because MNTX does not cross the blood-brain barrier, it could play a therapeutic role in reversing the peripheral effects of opiates in palliative care, especially for patients taking high doses of opiates for analgesia [32-37]",Pass,-,MNTX,0
3004649,https://doi.org/10.2147/JPR.S9243,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," In addition to its anti-diarrheal capabilities, Loperamide is a mu-opiate receptor agonist that does not penetrate the blood-brain barrier",Duplicate,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Loperamide,0
3044085,https://doi.org/10.1007/s11095-010-0291-7,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," The marker is a substance that does not penetrate the blood-brain barrier, e",Fail,-,,
3044085,https://doi.org/10.1007/s11095-010-0291-7,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," The marker is a substance that does not penetrate the blood-brain barrier, e",Fail,-,,
3044888,https://doi.org/10.1002/emmm.201000102,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, studies in whole animals reported that both FK506 and cyclosporine A, that does not cross the blood–brain barrier, have the same worsening effect on the phenotype of the disease (Hernandez-Espinosa & Morton, 2006), raising the question of whether it could be caused by extraneurological action of these immunomodulators",Pass,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cyclosporine A,0
3044888,https://doi.org/10.1002/emmm.201000102,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, studies in whole animals reported that both FK506 and cyclosporine A, that does not cross the blood–brain barrier, have the same worsening effect on the phenotype of the disease (Hernandez-Espinosa & Morton, 2006), raising the question of whether it could be caused by extraneurological action of these immunomodulators",Pass,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,FK506,0
3080346,https://doi.org/10.1186/1471-2407-11-124,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," This staining pattern has been described elsewhere [26,27] and is consistent with the fact that Hoechst 33342 does not cross the blood-brain barrier",Pass,CCOC1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C,Hoechst 33342,0
3124396,https://doi.org/10.2147/IJN.S17503,pmc,blood brain barrier permeability,.*inability to pass through the blood.brain barrier.*,"1 Although amphotericin B deoxycholate (AmB) continues to be the gold standard for treatment by selectively binding to ergosterol in the fungal cell membrane, which results in the leakage of intracellular contents and cellular death,2 clinical application of AmB against cryptococcal meningitis is limited due to its inability to pass through the blood–brain barrier (BBB)",Pass,-,amphotericin B deoxycholate,0
3125149,https://doi.org/10.1371/journal.pntd.0001151,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Berenil does not cross the blood-brain barrier, so although it is very effective in clearing parasites from the hemolymphatic system, it is unable to clear parasites from the CNS",Pass,CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N,Berenil,0
3151301,https://doi.org/10.1371/journal.pone.0023435,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As circulating somatostatin does not cross the blood-brain barrier (BBB), this finding leaves open that effects of the somatotropic axis on declarative memory consolidation are conveyed by GHRH",Pass,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O,somatostatin,0
3154262,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154262/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, CNTF is a large protein that does not cross the blood brain barrier,Pass,-,CNTF,0
3157762,https://doi.org/10.1155/2011/152474,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," For example, the short half-lives of native SOD and catalase in circulating blood and their inability to cross the blood-brain barrier limit their therapeutic usefulness in treating ischemic brain injury",Pass,-,catalase,0
3163371,https://doi.org/10.3797/scipharm.1012-08,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Because suramin and pentamidine are ionized at physiological pH, they are unable to cross the blood brain barrier in therapeutic concentrations and are thus used for the treatment of hemolymphatic early stage HAT, caused by T",Pass,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,pentamidine,0
3163371,https://doi.org/10.3797/scipharm.1012-08,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Because suramin and pentamidine are ionized at physiological pH, they are unable to cross the blood brain barrier in therapeutic concentrations and are thus used for the treatment of hemolymphatic early stage HAT, caused by T",Pass,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,suramin,0
3165907,https://doi.org/10.2147/IJNRD.S22783,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"“Serotonin does not cross the blood–brain barrier”5–7,31–69“Dopamine does not cross the blood–brain barrier”70–93“Norepinephrine does not cross the blood–brain barrier”94–107“Epinephrine does not cross the blood–brain barrier”",Pass,C1=CC(=C(C=C1CCN)O)O,Dopamine,0
3165907,https://doi.org/10.2147/IJNRD.S22783,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"“Serotonin does not cross the blood–brain barrier”5–7,31–69“Dopamine does not cross the blood–brain barrier”70–93“Norepinephrine does not cross the blood–brain barrier”94–107“Epinephrine does not cross the blood–brain barrier”",Pass,CNC[C@@H](C1=CC(=C(C=C1)O)O)O,Epinephrine,0
3165907,https://doi.org/10.2147/IJNRD.S22783,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"“Serotonin does not cross the blood–brain barrier”5–7,31–69“Dopamine does not cross the blood–brain barrier”70–93“Norepinephrine does not cross the blood–brain barrier”94–107“Epinephrine does not cross the blood–brain barrier”",Pass,C1=CC(=C(C=C1[C@H](CN)O)O)O,Norepinephrine,0
3165907,https://doi.org/10.2147/IJNRD.S22783,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"“Serotonin does not cross the blood–brain barrier”5–7,31–69“Dopamine does not cross the blood–brain barrier”70–93“Norepinephrine does not cross the blood–brain barrier”94–107“Epinephrine does not cross the blood–brain barrier”",Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,Serotonin,0
3170947,https://doi.org/10.1038/jcbfm.2011.51,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Peripheral administration of a much larger GLP-1–albumin recombinant fusion protein, which does not cross the blood–brain barrier, also activated neurons coupled to feeding in the central nervous system (Baggio et al, 2004)",Fail,-,,
3180521,https://doi.org/10.2147/CIA.S13109,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"66–68 Domperidone does not cross the blood–brain barrier, so only acts at peripheral dopamine receptors, releasing the “dopaminergic brake”",Duplicate,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,Domperidone,0
3199794,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199794/,pmc,blood brain barrier permeability,.*inability to pass through the blood.brain barrier.*," The low CNS toxicity of the new, ""non-sedative"" compounds is based primarily on the inability to pass through the blood-brain barrier",Fail,-,,
3209644,https://doi.org/10.1242/dmm.008185,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Although ERT has a marked effect on non-neurological manifestations, it has no demonstrable effect on neurological abnormalities because the enzyme does not cross the blood-brain barrier (Vellodi et al",Duplicate,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
3211030,https://doi.org/10.3390/ijms12107114,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Adriamycin does not cross the blood brain barrier [147], but it does cause a substantial increase in levels of TNF-α in serum, whole brain homogenate, and increased TNF-α staining in the hippocampus and cortex of mouse brain",Pass,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,Adriamycin,0
3229012,https://doi.org/10.4097/kjae.2011.61.5.358,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In open-chest rat hearts, a high dose of naloxone methiodide which does not cross the blood-brain barrier antagonized the infarct sparing effect by I-Pre in their study",Pass,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC=C.[I-],naloxone methiodide,0
3235999,https://doi.org/10.4137/CMO.S4259,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Imatinib undergoes rapid and extensive distribution into tissues, but does not cross the blood brain barrier in sufficient concentrations",Duplicate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Imatinib,0
3244463,https://doi.org/10.1371/journal.pone.0029504,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," As most of these drugs are recombinant enzymes that are unable to cross the blood-brain barrier (BBB), only non-neurological symptoms are treated",Fail,-,,
3253456,https://doi.org/10.1155/2012/460508,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Methyl mercury is easily absorbed through the gut and deposits in many tissues, but does not cross the blood-brain barrier as efficiently as elemental mercury; however, on entering the brain it is progressively demethylated to elemental mercury [5]",Pass,-,Methyl mercury,0
3263417,https://doi.org/10.2147/IJN.S26935,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, insolubility of quercetin in water results in poor absorption, low bioavailability, and inability to cross the blood–brain barrier, thereby limiting its potential clinical application in the treatment of cancer",Fail,-,,
3285636,https://doi.org/10.1371/journal.pone.0031610,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Therefore, in order to increase the amount of L-Dopa in the CNS, DDC inhibitors unable to cross the blood-brain barrier (BBB) are usually co-administered with L-Dopa",Fail,-,,
3303581,https://doi.org/10.1155/2012/251217,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Velcade is well distributed in the body and does not cross the blood-brain barrier,Pass,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,Velcade,0
3303591,https://doi.org/10.1155/2012/384017,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"Until three decades ago, insulin was considered only as a peripheral hormone, unable to cross the blood-brain barrier (BBB) and to affect the central nervous system (CNS) [3–5]",Fail,-,,
3307704,https://doi.org/10.1371/journal.pone.0031869,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, the usefulness of these inhibitors has been limited due to their toxicity or their inability to cross the blood-brain barrier",Fail,-,,
3316941,https://doi.org/10.1155/2012/862169,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Since AQP4-Ab does not penetrate the blood-brain barrier (BBB) under physiological condition [4], there should be at least the second trigger to break the integrity of the BBB and let AQP4-Ab get an access to their target antigen in the CNS",Pass,-,AQP4-Ab,0
3321303,https://doi.org/10.1155/2012/581695,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Since angiotensin II has a high molecular weight, it does not cross the blood-brain barrier (BBB) [78]",Pass,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,angiotensin II,0
3355882,https://doi.org/10.3389/fendo.2011.00062,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Although adiponectin was reportedly unable to cross the blood brain barrier (Spranger et al,Pass,-,adiponectin,0
3359765,https://doi.org/10.1155/2012/843649,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"It is well known that high levels of circulating cholesterol does not mean high cholesterol concentrations in brain tissue, essentially because cholesterol in the blood does not cross the blood brain barrier (BBB)",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
3377073,https://doi.org/10.1002/emmm.201100134,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," This molecule was chosen for its more selective effects compared to other Ih blockers, and, importantly, for its inability to cross the blood brain barrier (BBB)",Fail,-,,
3389445,https://doi.org/10.3389/fnint.2012.00021,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Since DA does not cross the blood-brain barrier (BBB), its precursor, LD, is given instead, with the intent that it will be taken up by DA neurons, converted to DA, and increase the release of DA by the remaining SNc neurons that project to the striatum",Duplicate,-,DA,0
3395437,https://doi.org/10.1155/2012/949048,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Methylmercury is easily absorbed through the gut, and it is deposited in most tissue but does not cross the blood-brain barrier as efficiently as elemental mercury",Duplicate,-,Methylmercury,0
3405876,https://doi.org/10.2147/IJN.S30320,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, Uncoated SPIONs have demonstrated low brain-targeting efficacy due to their inability to cross the blood-brain barrier,Fail,-,,
3439364,https://doi.org/10.1186/1471-2369-13-47,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," In accordance with these findings, it has been reported that peripheral angiotensins were unable to penetrate the blood–brain barrier (BBB) under normal physiological conditions [8]",Fail,-,,
3454363,https://doi.org/10.1371/journal.pone.0045783,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, We also observed that the strength of these emissions is correlated with the extravasation of an MRI contrast agent that normally does not penetrate the blood-brain barrier,Fail,-,,
3462207,https://doi.org/10.1371/journal.pone.0046676,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, The up-to-date consensus has been that the acetaldehyde that is peripherally derived does not penetrate the blood brain barrier in any significant amount [1],Fail,-,,
3467996,https://doi.org/10.2147/CE.S24743,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Icatibant has a poor diffusion in adipose tissue and does not cross the blood–brain barrier,Pass,C1CC[C@H]2[C@@H](C1)C[C@H](N2C(=O)[C@H]3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)NC(=O)CNC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H]7CCCN7C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,Icatibant,0
3477747,https://doi.org/10.5402/2012/701950,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, after systemic LPS, ions associated with LPS lipids were tracked and found to be bound to brain endothelium but were not found inside the brain, suggesting that LPS does not cross the blood-brain barrier [99]",Duplicate,-,LPS,0
3484857,https://doi.org/10.1242/dmm.010124,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Although cyclodextrin does not cross the blood-brain barrier efficiently, small amounts of cyclodextrin can enter the brain from the peripheral circulation",Pass,C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(O2)C(C7O)O)CO)CO)CO)CO)CO)O)O)O,cyclodextrin,0
3497307,https://doi.org/10.3390/ijms131012970,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, NMO IgG does not cross the blood brain barrier (BBB) in normal subjects [66] but it can cross the placenta [67],Pass,-,NMO IgG,0
3499491,https://doi.org/10.1371/journal.pone.0049670,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Moreover, analysis of cerebral cortex extracts from etanercept-treated ALF mice failed to show the presence of significant amount of etanercept in the brain, suggesting that the 150 kDa recombinant complex does not cross the blood-brain barrier (BBB) following AOM administration and that BBB integrity was maintained",Fail,-,,
3503402,https://doi.org/10.1155/2012/860923,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," However, the direct use of HGF has at least two major problems: (1) HGF is a large heterodimeric protein that is very expensive to produce; (2) as a large protein, HGF does not penetrate the blood-brain barrier and thus cannot reach brain locations where neurodegeneration is occurring",Pass,COCCOC1=CN=CC(=C1)C2=NC=C3C=CC4=C(C3=C2)NC5=C4C(=O)N=CC5,HGF,0
3528960,https://doi.org/10.1007/s10549-012-2328-6,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Because trastuzumab does not cross the blood–brain barrier (BBB), the CNS serves as a sanctuary for metastatic disease in the setting of sustained extracranial control and improved survival",Duplicate,-,trastuzumab,0
3603675,https://doi.org/10.1155/2013/612403,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Thiorphan does not cross the blood-brain barrier and, for this reason, orally administered racecadotril presents minimal centrally mediated opiate-like effects [49, 53]",Pass,C1=CC=C(C=C1)CC(CS)C(=O)NCC(=O)O,Thiorphan,0
3608917,https://doi.org/10.3389/fnins.2013.00036,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As serotonin does not cross the blood-brain barrier, central and peripheral serotonin form two distinct pools (Woolley and Shaw, 1954; Merritt et al",Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,serotonin,0
3633583,https://doi.org/10.2147/IJN.S42019,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Unlike the hepatic or renal Zn thioneins, the Zn-binding proteins in the brain are not inducible following administration of Zn as it does not cross the blood–brain barrier efficiently",Fail,-,,
3644410,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644410/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,Glutamate is a nonessential amino acid that does not cross the blood-brain barrier but must be synthesized inside neurons from local precursors (11),Duplicate,C(CC(=O)[O-])C(C(=O)[O-])[NH3+],Glutamate,0
3676832,https://doi.org/10.3390/ijms140510122,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," BDNF is extremely unstable in blood and does not penetrate the blood-brain barrier [117,118]",Duplicate,-,BDNF,0
3695222,https://doi.org/10.1371/journal.pone.0066847,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," CRP does not cross the blood-brain barrier (BBB) in trace amounts; however, during systemic inflammation and obesity, CRP may increase paracellular permeability of the BBB and impair BBB function [64]",Duplicate,-,CRP,0
3782835,https://doi.org/10.1155/2013/483145,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, [125] reported that obestatin is unable to cross the blood-brain barrier and is rapidly degraded in the circulation; this was confirmed by Vergote et al,Pass,-,obestatin,0
3818931,https://doi.org/10.2147/OAJU.S7233,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Although most of the agents are tertiary amines, trospium is a quaternary amine and does not cross the blood–brain barrier",Pass,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,trospium,0
3818931,https://doi.org/10.2147/OAJU.S7233,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Owing to its positive charge, trospium does not cross the blood–brain barrier, which theoretically reduces the potential of central nervous system adverse events",Duplicate,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,trospium,0
3871289,https://doi.org/10.1016/j.redox.2013.11.007,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Since cholesterol does not penetrate the blood–brain barrier, excess amounts of cholesterol in the brain are converted to 24SOHC, which readily crosses the blood–brain barrier to be eliminated [19]",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
3876306,https://doi.org/10.5811/westjem.2013.2.16210,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, It is strictly for treating inhalational symptoms: Raxibacumab does not cross the blood-brain barrier and does not prevent or treat meningitis,Pass,-,Raxibacumab,0
3881038,https://doi.org/10.3892/etm.2013.1419,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Since z-VAD-fmk does not penetrate the blood-brain barrier (19), it was applied intracerebroventricularly as a bolus injection to overcome this limitation",Pass,C[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1,z-VAD-fmk,0
3881671,https://doi.org/10.1155/2013/248072,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," This is attributable in particular to the better control of the systemic disease with chemotherapeutic agents or modern targeted substances, many of which are unable to cross the blood-brain barrier [17]",Fail,-,,
3884108,https://doi.org/10.2147/IJGM.S51665,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"89 Albiglutide does not cross the blood-brain barrier in a GLP-1 receptor-independent manner as does native GLP-190,91 and the smaller GLP-1 analogs exenatide92 and liraglutide,93 which may improve its gastrointestinal tolerability",Pass,CC[C@@H](C)[C@@H](C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC6=CN=CN6)N,Albiglutide,0
3913619,https://doi.org/10.1371/journal.pone.0087284,pmc,blood brain barrier permeability,.*does not pass through the blood.brain barrier.*," Since the low concentration of PTH normally does not pass through the blood brain barrier (BBB) [23], [24], the expression of the PTH2 receptor in the brain eventually led to the discovery of the natural ligand for the PTH2 receptor: a 39-residue peptide named tuberoinfundibular peptide (TIP39) [25]",Fail,-,,
3944747,https://doi.org/10.12703/P6-14,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Furthermore, these drugs may not similarly affect the cerebral vasculature due to their inability to cross the blood-brain barrier",Fail,-,,
3953678,https://doi.org/10.3389/fphys.2014.00096,pmc,blood brain barrier permeability,.*does not pass through the blood.brain barrier.*," PPADS does not pass through the blood brain barrier; therefore, the rats were infused by intracerebroventricular administration for 7 days after MCAO",Pass,CC1=C(C(=C(C(=N1)N=NC2=C(C=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)COP(=O)(O)O)C=O)O,PPADS,0
3983876,https://doi.org/10.1007/s12094-013-1110-5,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Moreover, the brain may represent a preferential site of metastasis as many of the currently available therapies are unable to cross the blood–brain barrier (BBB), even if this barrier is disrupted by tumor invasion",Fail,-,,
3983878,https://doi.org/10.1007/s00018-013-1509-8,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," As desferrioxamine does not penetrate the blood–brain barrier, this drug has obvious limitations for treatment inside the CNS, but it might be valuable for chelation of iron extracellularly in the brain, in particular in pathological conditions with a perturbed blood–brain barrier",Duplicate,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,desferrioxamine,0
3985759,https://doi.org/10.1021/ci5000196,pmc,blood brain barrier permeability,.*inability to pass through the blood.brain barrier.*,and its inability to pass through the blood–brain barrier (BBB),Fail,-,,
3990131,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"21,49 The same result was observed with asimadoline (a κ receptor agonist that does not cross the blood brain barrier) administration in healthy subjects",Pass,CN([C@H](CN1CC[C@@H](C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,asimadoline,0
4028550,https://doi.org/10.1007/s12026-014-8513-4,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Hypocretin does not cross the blood–brain barrier well, and although creating brain penetrating agonists for peptide receptor can be challenging, it is likely a matter of time before such compounds become available for treating daytime sleepiness and narcolepsy",Pass,-,Hypocretin,0
4034029,https://doi.org/10.3390/ph3041202,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,1 and being unable to cross the blood-brain barrier,Fail,-,,
4067234,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067234/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, we did not expect a direct effect of STZ on the effects detected since STZ was administered intraperitoneally and this drug does not cross the blood–brain barrier and is rapidly excreted in urine [74-77]",Pass,-,STZ,0
4113733,https://doi.org/10.3390/ph7070797,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, This may allow increased absorption into cells prior to hydrolysis and thus increased exposure to the active drug since MTIC itself does not cross the blood-brain barrier or effectively penetrate cells [38],Pass,CN=NNC1=C(NC=N1)C(=O)N,MTIC,0
4113733,https://doi.org/10.3390/ph7070797,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, This may allow increased absorption into cells prior to hydrolysis and thus increased exposure to the active drug since MTIC itself does not cross the blood-brain barrier or effectively penetrate cells [38],Duplicate,CN=NNC1=C(NC=N1)C(=O)N,MTIC,0
4119354,https://doi.org/10.15252/emmm.201303711,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Finally, it is important to note that blood cholesterol does not cross the blood brain barrier, making any beneficial effect of increased cholesterol in the diet unlikely and strongly unrecommended",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
4127280,https://doi.org/10.1155/2014/869269,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As nascent TNFR ECD is a large therapeutic molecule that does not cross the blood brain barrier (BBB), it was reengineered by fusion of the receptor protein to the carboxyl terminus of the chimeric monoclonal antibody (mAb) to the human insulin receptor (HIR)",Pass,-,nascent TNFR ECD,0
4127280,https://doi.org/10.1155/2014/869269,pmc,blood brain barrier permeability,.*inability to pass through the blood.brain barrier.*, Second it seems theoretically/falsely active but really it might show the inability to pass through the blood brain barrier with the adhered protein,Fail,-,,
4137762,https://doi.org/10.1021/mp500258p,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,the SGSH enzyme does not cross the blood–brain barrier (BBB),Fail,-,,
4148180,https://doi.org/10.1016/j.nbd.2014.06.011,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Based on its highly polar chemical structure, we have assumed that PSB-0739, the selective and potent P2Y12R antagonist, does not penetrate the blood–brain barrier",Fail,-,,
4210910,https://doi.org/10.3390/nu6104115,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," However, it may not be effective in therapy because it is a high molecular weight polypeptide (which is unable to cross the blood-brain barrier)",Pass,-,polypeptide,0
4210928,https://doi.org/10.3390/nu6104452,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," ApoE does not cross the blood brain barrier [8], suggesting that there is no exchange between brain ApoE and ApoE within lipoproteins and other organs",Duplicate,-,ApoE,0
4225054,https://doi.org/10.1007/s12035-014-8726-5,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In general, GABA does not cross the blood-brain barrier [129]",Duplicate,C(CC(=O)O)CN,GABA,0
4263172,https://doi.org/10.3389/fnbeh.2014.00396,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, This compound is unable to cross the blood-brain barrier (Savelieva et al,Fail,-,,
4294646,https://doi.org/10.2147/DDDT.S72165,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"77 However, use of both these molecules (MKT-077 and YM-01) in AD is limited by their inability to cross the blood–brain barrier and by their nephrotoxicity",Pass,-,MKT-077,0
4294646,https://doi.org/10.2147/DDDT.S72165,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"77 However, use of both these molecules (MKT-077 and YM-01) in AD is limited by their inability to cross the blood–brain barrier and by their nephrotoxicity",Pass,-,YM-01,0
4318704,https://doi.org/10.1002/mds.26075,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In addition, LRRK2-IN-1 does not cross the blood–brain barrier (BBB) and has numerous undesirable pharmacokinetic problems not easily remediated",Pass,CN1CCN(CC1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C)OC,LRRK2-IN-1,0
4319489,https://doi.org/10.3389/fendo.2015.00013,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"Insulin, after discovery in 1921, was initially considered a peripheral hormone and thus unable to cross the blood–brain barrier (BBB) (27)",Pass,CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CN=CN2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN,Insulin,0
4322880,https://doi.org/10.2147/OTT.S74110,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Because trastuzumab does not cross the blood–brain barrier (BBB) due to its high molecular weight (180 kDa), the growing incidence of BM among patients with metastatic breast cancer (MBC) treated with trastuzumab, especially in the setting of controlled extracranial disease, has been attributed to the more frequent diagnosis of CNS involvement that would be otherwise clinically silent before death, due to the aggressive course of the disease in the pre-trastuzumab era",Pass,-,trastuzumab,0
4327740,https://doi.org/10.3389/fphar.2014.00284,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," According to the literature, D-AP5 does not cross the blood brain barrier (BBB) in rodents (Kapur and Lothman, 1990)",Pass,C(C[C@H](C(=O)O)N)CP(=O)(O)O,D-AP5,0
4347504,https://doi.org/10.3389/fnbeh.2015.00051,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As adrenaline does not cross the blood-brain barrier, these central effects suggest the existence of a peripheral-central pathway by which adrenaline can modulate processes in the central nervous system (Izquierdo et al",Pass,CNCC(C1=CC(=C(C=C1)O)O)O,adrenaline,0
4403851,https://doi.org/10.1186/s12974-015-0281-0,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," DSS is a large molecule (molecular weight (MW) 30,000 to 50,000) that does not cross the blood-brain barrier",Duplicate,-,DSS,0
4411110,https://doi.org/10.1371/journal.pone.0124510,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, none of these PAI-1 antagonists have been investigated in CNS diseases models because of their inability to cross the blood brain barrier (BBB)",Fail,-,,
4444132,https://doi.org/10.4137/BCBCR.S21176,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,The rationale for the potential positive effects of eribulin on brain metastases requires explanation because preclinical evidence suggests that the agent does not cross the blood–brain barrier (BBB) to a significant extent,Pass,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O,eribulin,0
4453146,https://doi.org/10.1259/bjr.20140134,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"37 Although MGd does not cross the blood–brain barrier (BBB) in healthy brains, MRI revealed its uptake in the brain tumour tissue of glioblastoma multiform (GBM) patients",Pass,-,MGd,0
4454520,https://doi.org/10.1371/journal.pone.0128313,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, The cyclodextrin vehicle SBECD does not cross the blood brain barrier [47] but instead facilitates Allo release to steroid carrier proteins in blood,Fail,-,,
4463817,https://doi.org/10.14814/phy2.12381,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"25, dextrose 10; Human Insulin, a polypeptide hormone produced by the β-cells of pancreatic islets (Lilly, Indianapolis, IN, EUA) for LV (100 nU/μL) and intracarotid injection (100 nU); Atropine methyl-bromide (ATROP, 2 mg/kg), a competitive muscarinic receptor antagonist that does not cross the blood–brain barrier; Phentolamine (PHENT, 3 mg/kg), an α-adrenoceptor antagonist; Propranolol hydrochloride (PROP, 0",Pass,-,Atropine methyl-bromide,0
4472125,https://doi.org/10.1038/boneres.2014.34,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,267 These results suggest that an orally active inhibitor of gut TPH1 that does not cross the blood–brain barrier might be a novel anabolic agent for treating osteoporosis,Pass,-,TPH1,0
4486648,https://doi.org/10.1038/mp.2015.28,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"53 However, the HCN1 antagonist ivabradine, approved in Europe for angina, does not cross the blood–brain barrier",Fail,-,,
4499110,https://doi.org/10.1007/s10620-015-3615-y,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Loperamide does not cross the blood–brain barrier and does not have these adverse effects,Duplicate,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Loperamide,0
4536273,https://doi.org/10.1007/s11064-015-1675-1,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Under normal circumstances, glutamate does not cross the blood–brain barrier [45]",Duplicate,C(CC(=O)[O-])C(C(=O)[O-])[NH3+],glutamate,0
4562999,https://doi.org/10.1007/s10237-015-0662-4,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"Infusion is a procedure during which fluid is injected into the brain, either to administer drugs, which cannot enter from the vasculature as they are unable to cross the blood brain barrier, or to investigate cerebral compliance of the brain",Fail,-,,
4567234,https://doi.org/10.2147/OPTH.S78368,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,13 These penetration problems at privileged sites and the fact that the enzyme does not cross the blood–brain barrier may explain the lack of effect of ERT on neurologic symptoms,Fail,-,,
4594160,https://doi.org/10.3389/fpsyg.2015.01520,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Interestingly, GABA has long been thought to be unable to cross the blood–brain barrier (BBB), which raises questions about the mechanisms of action behind such beneficial effects (Roberts et al",Duplicate,C(CC(=O)O)CN,GABA,0
4608735,https://doi.org/10.1371/journal.pone.0140733,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," These advantages have made aptamers excellent alternatives for diagnostic and therapeutic agents in CNS related pathologies, because antibody-based approaches have not demonstrated adequate sensitivity in most cases, whereas they have exhibited toxicity in vivo and the inability to cross the blood-brain barrier (BBB) efficiently",Fail,-,,
4633805,https://doi.org/10.1021/cr500365f,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,does not cross the blood-brain barrier,Fail,-,,
4633805,https://doi.org/10.1021/cr500365f,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"does not cross the blood-brain barrier, hence its use is limited to",Fail,-,,
4641856,https://doi.org/10.5217/ir.2015.13.4.306,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In addition, loperamide does not cross the blood-brain barrier well, suggesting no central side effects or risk of dependence",Pass,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,loperamide,0
4664815,https://doi.org/10.1155/2015/515248,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"A problem with TNF alpha inhibition, via monoclonal antibody treatment or synthetic antibody linked TNF receptors, is that the molecules utilized are large and generally unable to cross the blood brain barrier",Fail,-,,
4675809,https://doi.org/10.1016/j.apsb.2015.08.001,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Neurological abnormalities were found to be decreased in mice that underwent TBI with prior intracerebral injection of LHVS, a vinyl sulfone cathepsin S inhibitor that does not penetrate the blood–brain barrier91",Pass,CC(C)C[C@@H](C(=O)N[C@@H](CCC1=CC=CC=C1)/C=C/S(=O)(=O)C2=CC=CC=C2)NC(=O)N3CCOCC3,LHVS,0
4681825,https://doi.org/10.1155/2015/940207,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Until recently it was considered that tadalafil was unable to cross the blood-brain barrier (BBB) [10], but the most recent results have shown that tadalafil reaches the brain in sufficient concentrations to potently inhibit PDE5 [11]",Fail,-,,
4693272,https://doi.org/10.3390/biom5043112,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Under normal physiological conditions, peripheral glutamate is unable to cross the blood-brain barrier (BBB) [195]",Fail,-,,
4752587,https://doi.org/10.1007/s10295-015-1686-6,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," While avermectin can bind GABA receptors in the mammalian central nervous system, the pharmacological effectiveness of the drug is owed to its inability to cross the blood–brain barrier [160, 161]",Pass,CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,avermectin,0
4763217,https://doi.org/10.1038/srep21973,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," These complications relate to the fact that HPβCD does not cross the blood-brain barrier62, with the result that current treatment involves direct administration to CSF",Duplicate,-,HPbetaCD,0
4786902,https://doi.org/10.12688/f1000research.7378.1,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,in vivo because of inability to cross the blood-brain barrier,Fail,-,,
4814575,https://doi.org/10.1038/ncomms11017,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, leakage of tail vein-injected cadaverine-Alexa-555, a small tracer that normally does not cross the blood–brain barrier19, was reduced in the Vegfr2Y949F/Y949F gliomas compared with WT at D18, both intratumourally and in the tumour periphery (0–500 μm peritumourally; Fig",Pass,-,cadaverine-Alexa-555,0
4814697,https://doi.org/10.1155/2016/7825396,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, S100B does not penetrate the blood-brain barrier and therefore it is not found in peripheral blood under normal circumstances [13],Pass,-,S100B,0
4870226,https://doi.org/10.3390/molecules20069550,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Unfortunately, this radiotracer does not cross the blood-brain barrier, and attempts to circumvent this limitation by manipulation of its lipophilicity were ineffective [23]",Fail,-,,
4904796,https://doi.org/10.1038/srep28009,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Serotonin does not cross the blood-brain barrier, thus, tryptophan can give rise to two separate pools of serotonin in the brain and in the periphery, where it is mostly found in the gastrointestinal mucosa29",Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,Serotonin,0
4917524,https://doi.org/10.3389/fncel.2016.00167,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, etanercept does not cross the blood-brain barrier (BBB) when administered systemically (Banks et al",Pass,-,etanercept,0
4939703,https://doi.org/10.1093/brain/aww096,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*,"C-8’-hydroxy-DHE, is also radioactive, and the lack of binding in PET indicates that it does not penetrate the blood–brain barrier either",Pass,-,C-8’-hydroxy-DHE,0
4939703,https://doi.org/10.1093/brain/aww096,pmc,blood brain barrier permeability,.*was not able to cross the blood.brain barrier.*,C-DHE was not able to cross the blood–brain barrier,Pass,-,C-DHE,0
4943055,https://doi.org/10.5935/0103-507X.20160020,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,over atropine as it does not cross the blood-brain barrier to cause central,Fail,-,,
5011512,https://doi.org/10.1155/2016/2794096,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*, GABA itself is unable to penetrate the blood-brain barrier and systemic intraperitoneal administration of GABA is not accompanied by anticonvulsive activity [6],Duplicate,C(CC(=O)O)CN,GABA,0
5031928,https://doi.org/10.5498/wjp.v6.i3.283,pmc,blood brain barrier permeability,.*unable to pass through the blood.brain barrier.*,"Because peripheral cytokines are hydrophilic and have large molecular weights, they are unable to pass through the blood-brain barrier (BBB) in their normal state",Fail,-,,
5041943,https://doi.org/10.18632/oncotarget.8370,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Because of its rarity and drugs’ inability to cross the blood-brain barrier, optimal treatment is limited",Fail,-,,
5049676,https://doi.org/10.1111/aas.12601,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Alvimopan is a peripherally acting μ‐opioid receptor antagonist, which does not cross the blood–brain barrier readily",Pass,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,Alvimopan,0
5064756,https://doi.org/10.1530/ERC-16-0140,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Once injected, PEG does not cross the blood–brain barrier and therefore does not exert a biological effect on the CNS (Veldhuis et al",Pass,C(CO)O,PEG,0
5067323,https://doi.org/10.1155/2016/3160486,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," DA is unable to cross the blood-brain barrier; thus, signaling in the neuronal DAS should be independent of that of the DAS in peripheral systems [11]",Duplicate,-,DA,0
5069291,https://doi.org/10.3389/fnins.2016.00459,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*,", 1997), while rosiglitazone does not penetrate the blood brain barrier at all (Chalimoniuk et al",Pass,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,rosiglitazone,0
5089983,https://doi.org/10.3389/fnmol.2016.00106,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Reducing specifically peripheral inflammation, using anti-TNF-a, which does not cross the blood-brain barrier, reduces neuroinflammation, translocates NF-kB to the nucleoli, normalizes TNF-a and IL-1b in hippocampus, membrane expression of AMPA receptors and spatial learning and memory",Duplicate,-,anti-TNF-a,0
5089983,https://doi.org/10.3389/fnmol.2016.00106,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"The present report provides the first demonstration that reducing specifically peripheral inflammation, using anti-TNF-a, which does not cross the blood-brain barrier, prevents the induction of neuroinflammation, the changes in membrane expression of AMPA receptors and associated impairment of spatial learning and memory in rats with HE due to PCS",Fail,-,,
5168823,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168823/,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,Doxorubicin is not a standard treatment for glioblastoma due to its inability to cross the blood brain barrier,Pass,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,Doxorubicin,0
5168823,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168823/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"While we identified a novel therapeutic strategy that results in cell death in vitro, doxorubicin is not currently a viable chemotherapy for glioblastoma as it does not cross the blood brain barrier; however, understanding how inhibition of the CBX proteins can improve response to DNA damaging agents is an important area of research",Duplicate,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,doxorubicin,0
5214462,https://doi.org/10.1038/srep40214,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Given that it is known that PSB1115 does not cross the blood-brain barrier38, this result suggests that A2BARs expressed on peripheral tissues (such as the large intestine) rather than those expressed in the central nervous system mediate the inhibitory effect of aminophylline on visceral hypersensitivity",Pass,CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)O,PSB1115,0
5319242,https://doi.org/10.4103/1673-5374.198964,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, The therapeutic potential of BDNF is restricted due to its short half-life (< 10 minutes) and inability to cross the blood-brain barrier (BBB) because of its large size (27 kDa) (Price et al,Duplicate,-,BDNF,0
5334527,https://doi.org/10.1111/acel.12553,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Although BDNF is a vital neurotrophic factor, its limited delivery, short half‐life and inability to cross the blood–brain barrier hinder its effectiveness as a therapeutic agent",Duplicate,-,BDNF,0
5376751,https://doi.org/10.1002/acn3.399,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"27, 28 Due to its large size, apoE does not cross the blood–brain barrier (BBB) and its therapeutic potential is limited",Pass,-,apoE,0
5382357,https://doi.org/10.1155/2017/5064683,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Also, CBX does not penetrate the blood-brain barrier [36]",Duplicate,-,CBX,0
5403925,https://doi.org/10.3389/fnins.2017.00220,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Cholesterol in brain cells is derived primarily from de novo synthesis since lipoproteins are unable to cross the blood-brain barrier (BBB; Valdez et al,Fail,-,,
5412467,https://doi.org/10.3390/ijms18040888,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," As discussed above, ERT has the disadvantage of being expensive; in addition, it does not impact neurological symptoms due to its inability to cross the blood–brain barrier due to its size",Duplicate,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
5412694,https://doi.org/10.2174/1570159X14666160307145542,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," While many analgesic drugs may be given systemically to exert their spinal action, the specific use of the intrathecal or epidural route for analgesic drug delivery may be employed for three reasons: i) the drug target lies at the spinal level (opiates, baclofen); ii) the agent does not penetrate the blood brain barrier (antisense, toxins); and/or iii) the agent penetrates the blood brain barrier but does so at systemic doses that produce undesirable side effects, so spinal delivery increases the therapeutic index (e",Fail,-,,
5423911,https://doi.org/10.3389/fphar.2017.00245,pmc,blood brain barrier permeability,.*unable to pass through the blood.brain barrier.*," Typically, drugs with molecular weights larger than 400–500 Da that form more than 8–10 hydrogen bonds with surrounding water molecules are unable to pass through the blood-brain barrier (Pardridge, 2005; Upadhyay and Upadhyay, 2014)",Fail,-,,
5456330,https://doi.org/10.3390/diseases4040033,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," This approach, however, fails to correct the neurological symptoms, since recombinant enzymes are unable to cross the blood brain barrier (BBB) [28]",Fail,-,,
5456331,https://doi.org/10.3390/diseases5010010,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, this treatment does not cross the blood–brain barrier, and is therefore ineffective in reversing neurological dysfunction in patients with GD disease types 2 and 3",Fail,-,,
5456331,https://doi.org/10.3390/diseases5010010,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"While some patients with neuronopathic GD can benefit from ERT because of its effect on hematologic and visceral symptoms, it has no impact on brain involvement because it does not cross the blood–brain barrier",Duplicate,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
5483959,https://doi.org/10.1186/s12943-017-0679-7,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Although it is likely playing a critical role in the brain, tumour targeted delivery or the use of inhibitors that are unable to cross the blood-brain barrier may present as viable future therapeutic options",Fail,-,,
5547238,https://doi.org/10.1016/j.neo.2017.05.007,pmc,blood brain barrier permeability,.*unable to pass through the blood.brain barrier.*," The uptake of Evans blue, an azo dye with high affinity for albumin used to assess the degree of tumor vascular permeability, and unable to pass through the blood brain barrier, was lower in B20",Fail,-,,
5589771,https://doi.org/10.1038/s41598-017-11302-0,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, The most important reported reason for the failure of most inhibitors during the clinical trials was their inability to cross the blood-brain barrier to penetrate and distribute inside neurons,Fail,-,,
5618243,https://doi.org/10.3390/biom7030062,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Cytokines in the brain, such as TNF-α, are elevated after systemic LPS injection, even though LPS itself does not cross the blood–brain barrier [102]",Duplicate,-,LPS,0
5643283,https://doi.org/10.3748/wjg.v23.i36.6593,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"LX-1031 does not cross the blood-brain barrier and, thus, does not pose risk of depression[228]",Pass,COC1=CC=CC(=C1)C2=CC=C(C=C2)[C@H](C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N,LX-1031,0
5697612,https://doi.org/10.1002/cpdd.345,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"49 The novel radioligand 11C‐dihydroergotamine, chemically identical to active dihydroergotamine, was unable to cross the blood–brain barrier in 6 control subjects and 6 migraineurs, ictally or interictally, demonstrating that the blood–brain barrier remains tight during acute glyceryl trinitrate‐induced migraine attacks",Pass,-,11C‐dihydroergotamine,0
5733106,https://doi.org/10.3389/fphar.2017.00913,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Consistent with the effect of adenosine in modulating ventilation via CB chemoreceptors, intra-arterially administration of adenosine in dog and cats showed that adenosine does not cross the blood brain barrier (Berne et al",Pass,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,adenosine,0
5766510,https://doi.org/10.1038/s41598-017-18747-3,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," The lack of effect of 2-F-4-AP can be explained by the lack of binding to the channel, as demonstrated in the previous experiments, whereas the lack of effect of 3-HOMe-4-AP is likely due to its inability to cross the blood-brain barrier (BBB) as predicted by its cLogP of −0",Pass,-,3-HOMe-4-AP,0
5781280,https://doi.org/10.1186/s40409-018-0139-x,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," According to Freire-Maia and Campos [31], the central effects would be the result and not the cause of the envenoming process, since the venom would be unable to cross the blood-brain barrier",Fail,-,,
5830467,https://doi.org/10.1007/s11940-018-0490-9,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, RMP does not penetrate the blood-brain barrier (BBB) as well with concentrations in CSF only 10–20% of that reached in plasma [9],Pass,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,RMP,0
5832807,https://doi.org/10.1038/s41598-018-22162-7,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, It chelates cholesterol but does not cross the blood brain barrier (BBB)26,Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
5842689,https://doi.org/10.1155/2018/3941840,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, early studies have shown that paclitaxel does not cross the blood-brain barrier (BBB) to affect neurons in the central nervous system [17]",Duplicate,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,paclitaxel,0
5842689,https://doi.org/10.1155/2018/3941840,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,Previous studies have shown that the neuropathy of paclitaxel is limited to peripheral sensory nerves through affecting axonal degeneration in sensory nerves [14–16] because paclitaxel does not cross the blood-brain barrier (BBB) [17],Duplicate,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,paclitaxel,0
5843686,https://doi.org/10.1007/s00018-017-2691-x,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,The key limitation of NTs in the treatment of PNS and CNS diseases is their inability to cross the blood–brain barrier,Fail,-,,
5869259,https://doi.org/10.3389/fgene.2018.00087,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,", 2010), whereas others have argued that it does not cross the blood–brain barrier (Pardridge et al",Fail,-,,
5874248,https://doi.org/10.1038/s41426-018-0044-y,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Interestingly, no evidence of disease or pathology was reported after peripheral administration of the virus, suggesting that ZIKV does not cross the blood–brain barrier (BBB) of newborn piglets",Pass,-,ZIKV,0
5918142,https://doi.org/10.1016/j.tranon.2018.03.014,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"A phosphorylated aminothiol prodrug [31], amifostine is dephosphorylated by the enzyme, alkaline phosphatase that is at high levels in normal tissues but at low levels in tumors and thus converted to its active free radical-scavenging sulfhydryl metabolite, WR-1065, which provides a selective mechanism for protection of non-CNS tissues (since amifostine does not cross the blood brain barrier)",Pass,C(CN)CNCCSP(=O)(O)O,amifostine,0
5934683,https://doi.org/10.1093/nutrit/nuy004,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Serotonin does not cross the blood–brain barrier, so it must be synthesized within the brain, and synthesis is in large part dependent on the availability of tryptophan",Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,Serotonin,0
5983708,https://doi.org/10.3390/ijms19051312,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, their plasma delivery in pure protein form is rather ineffective, often due to their poor pharmacokinetic profiles and inability to cross the blood–brain barrier in substantial amounts [34]",Fail,-,,
5983708,https://doi.org/10.3390/ijms19051312,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," NTs might be an interesting treatment tool for various neurodegenerative disorders; however, their poor pharmacokinetic profiles (primarily their inability to cross the blood–brain barrier (BBB) and short half-life) make their application in a protein form largely ineffective [18,19]",Fail,-,,
6015065,https://doi.org/10.1038/s41598-018-27926-9,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"5% reaches the brain upon systemic administration due to its inability to cross the blood brain barrier (BBB)25,53",Fail,-,,
6031986,https://doi.org/10.3988/jcn.2018.14.3.291,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, some studies have found that GABA does not cross the blood-brain barrier (BBB),24 although others found that small amounts of GABA did cross the BBB",Duplicate,C(CC(=O)O)CN,GABA,0
6034193,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034193/,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Glutamate itself, used as a spice, does not cross the blood-brain barrier",Duplicate,C(CC(=O)[O-])C(C(=O)[O-])[NH3+],Glutamate,0
6048981,https://doi.org/10.3389/fpubh.2018.00185,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," In a four-organ system, the gut and liver metabolized the toxic terfenadine to its nontoxic and vasoactive form fexofenadine which was unable to cross the blood-brain barrier (70)",Pass,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,fexofenadine,0
6092511,https://doi.org/10.3389/fncel.2018.00226,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Taxol does not cross the blood brain barrier,Pass,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Taxol,0
6103555,https://doi.org/10.2147/IJN.S170564,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"9 Importantly, unformulated 3BP is not suitable for treating nervous system tumors as 3BP does not cross the blood–brain barrier (BBB)",Pass,CCS(=O)(=O)N[C@H](CC1=CC=C(C=C1)C2=CC=CC=C2)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC3=CC=C(C=C3)C(=N)N,3BP,0
6120113,https://doi.org/10.2174/1570159X15666171129100944,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Because DA by itself does not cross the blood-brain barrier, levodopa which is metabolized to DA in the body is used as the bedrock of Parkinson’s therapy",Pass,-,DA,0
6121012,https://doi.org/10.3389/fnmol.2018.00297,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, the therapeutic potential of BDNF is restricted, due to its relatively short half-life of less than 10 min, and inability to cross the blood-brain barrier (BBB; Wurzelmann et al",Duplicate,-,BDNF,0
6128908,https://doi.org/10.1038/s41598-018-31680-3,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Several other compounds within this series were tested for brain penetration and were likewise unable to cross the blood brain barrier,Fail,-,,
6134067,https://doi.org/10.3389/fncel.2018.00293,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," It has recently been shown that CNO does not cross the blood brain barrier in naive rats, but is rather metabolized to clozapine that can cross the blood brain barrier and activate DREADDs directly (Gomez et al",Pass,C[N+]1(CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42)[O-],CNO,0
6160447,https://doi.org/10.1038/s41531-018-0066-0,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Leads were exteriorized, prior to suturing the abdominal laparotomy; the jugular vein was catheterized to permit systemic administration of bethanechol (10 µg/kg), a muscarinic agonist that does not cross the blood-brain barrier and excites the smooth muscle directly supramaximally",Pass,CC(C[N+](C)(C)C)OC(=O)N,bethanechol,0
6164360,https://doi.org/10.3390/ijms19092749,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Despite BDNF’s neuroprotective ability against ischemic damage, treating patients with BDNF remains challenging because BDNF is unable to cross the blood-brain barrier [49,50]",Duplicate,-,BDNF,0
6167477,https://doi.org/10.3389/fnmol.2018.00334,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,EPI is a polar molecule that does not cross the blood-brain barrier (Weil-Malherbe et al,Duplicate,-,EPI,0
6167477,https://doi.org/10.3389/fnmol.2018.00334,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"However, EPI is a hydrophilic hormone and does not cross the blood-brain barrier (Weil-Malherbe et al",Pass,-,EPI,0
6198223,https://doi.org/10.1080/03009734.2018.1489918,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, reviewed published data on the safety profile of desloratadine and concluded that it has no CNS effects and does not cross the blood–brain barrier (24),Fail,-,,
6198615,https://doi.org/10.1155/2018/9150207,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Neostigmine does not cross the blood–brain barrier (BBB) located in the endothelial cells of brain microvessels nor the blood-cerebrospinal barrier situated in the epithelial cells of the CP [31],Pass,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,Neostigmine,0
6203993,https://doi.org/10.1186/s12974-018-1328-9,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Although LPS does not cross the blood-brain barrier at significant levels [20], it could be interacting with juxta-cerebrovascular cells to transmit an immune signal across the barrier",Pass,-,LPS,0
6244951,https://doi.org/10.3390/molecules13010046,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, DA deficiency appears to be responsible for the motor deficits of the disorder but PD cannot be treated directly with DA or related catecholamines due to their inability to cross the blood brain barrier (BBB),Duplicate,-,DA,0
6250245,https://doi.org/10.1097/CCM.0000000000003427,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Minimal uptake of Klotho was found in the brain (6), suggesting that rKL is unable to cross the blood brain barrier (BBB)",Pass,C1=CC=C2C(=C1)N=C3C4=C(C5=C(C3=N2)C=CC=N5)N=CC=C4.C1=CC2=NC=CN=C2C3=NC=CN=C31.C1=CC2=NC=CN=C2C3=NC=CN=C31.[Ru],rKL,0
6278276,https://doi.org/10.3390/molecules23113019,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,", ABT-737) showed strong neuroprotective effects by blocking accumulation of ΔN-Bcl-xL but this drug does not cross the blood-brain barrier [18,68,104]",Pass,CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-],ABT-737,0
6321593,https://doi.org/10.3390/pharmaceutics10040181,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Many molecules are described having action in the brain disorders that fail clinical testing, due to their inability to cross the blood–brain barrier (BBB)",Fail,-,,
6337414,https://doi.org/10.3390/molecules24010049,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," However, [18F]-53 was unable to penetrate the blood–brain barrier (BBB), which would preclude its use as a radiotracer for visualization of neuroinflammation in vivo",Fail,-,,
6378738,https://doi.org/10.1186/s13023-019-1027-3,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, since IV laronidase does not cross the blood-brain barrier, it does not treat the CNS manifestations of MPS I, and thus patients may experience neurocognitive deficits throughout life",Fail,-,,
6406402,https://doi.org/10.3390/cancers11020229,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Additionally, it was found that 3-BP does not cross the blood–brain barrier, which limits its neurotoxic potential [36]",Pass,C(C(=O)C(=O)O)Br,3-BP,0
6407211,https://doi.org/10.1186/s12883-019-1267-9,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," In contrast to KYN, KYNA is unable to cross the blood brain barrier (BBB)",Pass,C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O,KYNA,0
6413434,https://doi.org/10.1177/2045125318818814,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"44 Since serotonin does not cross the blood–brain barrier, central",Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,serotonin,0
6433723,https://doi.org/10.1111/jcmm.14206,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Thirdly, RR has a strong positive charge and does not cross the blood‐brain barrier",Pass,-,RR,0
6497083,https://doi.org/10.1016/j.celrep.2019.03.079,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," Because clofazimine was unable to penetrate the blood-brain barrier at physiological dosages, we propose that Cx46 future derivatization of the compound is required to permeate the blood-brain barrier and may produce an optimal targeting drug for GBM CSCs",Pass,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,clofazimine,0
6511348,https://doi.org/10.1007/s12031-019-01307-x,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," The final, inactive, olanzapine metabolite 10-N-glucuronide does not cross the blood-brain barrier (Aravagiri et al",Pass,-,10-N-glucuronide,0
6514324,https://doi.org/10.1016/j.tranon.2019.04.006,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"In spite of these promising results, FF does not cross the blood-brain barrier (BBB) [4] and is quickly converted to FA by blood and tissue esterases (Figure 4A and [4])",Pass,-,FF,0
6514564,https://doi.org/10.3390/molecules24081583,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," The main reason behind this is that most of the antioxidants have permeability limitations, owing to which antioxidants are unable to cross the blood–brain barrier",Fail,-,,
6537633,https://doi.org/10.1093/neuros/nyy365,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," ALA for itself does not cross the blood-brain barrier,40 whereas FET uptake appears to depend on a blood-brain barrier bound L-type amino acid transporter",Pass,-,ALA,0
6551797,https://doi.org/10.15698/cst2018.07.143,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," The first generation of large-molecule drugs failed because of their unfavorable pharmacological properties, such as the inability to cross the blood-brain barrier (BBB), and the second generation of small-molecule compounds still could not effectively penetrate the BBB 71",Fail,-,,
6559804,https://doi.org/10.1016/j.neuron.2019.03.045,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Because TERI does not cross the blood-brain barrier efficiently (Vidal-Jordana et al,Pass,-,TERI,0
6624455,https://doi.org/10.1002/prp2.499,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, These results indicate that desloratadine 5 mg does not penetrate the blood‐brain barrier in large amounts enough to induce inhibition of H1R signaling resulting in sedation and cognitive impairment,Pass,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4, desloratadine,0
6631469,https://doi.org/10.3390/ph12020099,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, It was shown that the nociceptive behaviour and mechanical hypersensitivity in CFA-induced mice was significantly inhibited by GABAAR antagonists picrotoxin (a non-competitive GABAAR inhibitor) and bicuculline (a competitive inhibitor unable to cross the blood-brain barrier),Pass,CN1CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3,bicuculline,0
6632112,https://doi.org/10.3390/ncrna5020035,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"The central nervous system (CNS) is traditionally thought of as an immune-privileged site, separated from peripheral immune cells that are unable to cross the blood brain barrier (BBB) under normal conditions [1]",Fail,-,,
6636655,https://doi.org/10.4274/balkanmedj.galenos.2019.2019.5.62,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Mast cells can penetrate all human tissues, including brain tissue, in which no allergic reactions occur owing to IgE antibodies being unable to cross the blood–brain barrier",Fail,-,,
6651136,https://doi.org/10.3390/ijms20133304,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, They are ineffective in neuronopathic GD because they are unable to cross the blood–brain barrier,Fail,-,,
6656724,https://doi.org/10.1038/s42003-019-0520-5,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In contrast, no reduction of [3H]-3-HK was detected in rats receiving an intravenous infusion of Ro 61-8048 (50 mg/kg), a KMO inhibitor that does not cross the blood–brain barrier4,12",Pass,COC1=C(C=C(C=C1)S(=O)(=O)NC2=NC(=CS2)C3=CC(=CC=C3)[N+](=O)[O-])OC,Ro 61-8048,0
6690581,https://doi.org/10.1371/journal.pone.0217194,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," This implies that peripheral 6-OHDA, which does not cross the blood-brain barrier [59], can directly affect enteric microbiota",Duplicate,C1=C(C(=CC(=C1O)O)O)CCN,6-OHDA,0
6696273,https://doi.org/10.3390/ijms20153810,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Noticeably, brain cholesterol comes almost entirely from the endogenous synthesis, being circulating cholesterol unable to cross the blood-brain barrier (BBB) [5]",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
6701226,https://doi.org/10.3389/fncel.2019.00351,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Furthermore, the factor does not cross the blood brain barrier (BBB) and often has serious side effects when administered systemically, necessitating an effective drug delivery strategy to reach the brain",Fail,-,,
6720569,https://doi.org/10.3390/antiox8080311,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,The intake of tryptophan and 5-hydroxytryptophan is essential for the formation of serotonin in the brain because this neurotransmitter does not cross the blood-brain barrier and the synthesis and turnover of serotonin depends on the ingestion of those compounds [13],Duplicate,C1=CC2=C(C=C1O)C(=CN2)CCN,serotonin,0
6734463,https://doi.org/10.1186/s10194-019-0984-1,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Because histamine is unable to cross the blood-brain barrier and H1 receptors are present in the endothelium of cerebral arteries, migraine attacks could have an origin in the walls of intracerebral arteries and not in the brain itself [41]",Pass,C1=C(NC=N1)CCN,histamine,0
6734463,https://doi.org/10.1186/s10194-019-0984-1,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Furthermore, Nα-methylhistamine does not cross the blood brain barrier",Pass,CNCCC1=CN=CN1,Nalpha-methylhistamine,0
6769076,https://doi.org/10.3389/fonc.2019.00933,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Nevertheless, since the compounds are unable to cross the blood-brain barrier and reach their molecular targets in the brain, they are ineffective when applied in vivo",Fail,-,,
6794430,https://doi.org/10.3389/fphar.2019.01130,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*," However, short biological half-lives and inability to penetrate the blood-brain barrier (BBB) of protein factors greatly limit application of which in clinical usage",Fail,-,,
6805667,https://doi.org/10.1186/s13023-019-1207-1,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," The improvements in measurable neurocognitive function in some patients, as well as the unsolicited reports of increased alertness and focus in even the most severely affected patients, conflict with our prior notion that HPβCD does not cross the blood brain barrier (BBB) and would therefore not be expected to affect clinically apparent change [74]",Duplicate,-,HPbetaCD,0
6822456,https://doi.org/10.1186/s12974-019-1580-7,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, DSS does not cross the blood–brain barrier because of its higher molecular weight,Duplicate,-,DSS,0
6822712,https://doi.org/10.1371/journal.pone.0224022,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," In some studies, the neurotrophins were administered systemically, so their potential therapeutic effects in the brain were likely compromised by the rapid degradation of these proteins in the blood and by an inability to cross the blood-brain barrier [63]",Fail,-,,
6829263,https://doi.org/10.3390/cells8101203,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Clinically, a selective muscarinic M3 receptor antagonist has been FDA approved to treat overactive bladder, however, it appears that this drug does not cross the blood–brain barrier [78,79]",Fail,-,,
6830204,https://doi.org/10.1080/19768354.2019.1651768,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," 2009); however, it does not cross the blood–brain barrier (BBB) (Pontikis et al",Fail,-,,
6835930,https://doi.org/10.3390/metabo9100208,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, because DOX does not cross the blood–brain barrier [11,12], inflammatory effects must be indirect",Pass,-,DOX,0
6843313,https://doi.org/10.3390/biom9100562,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Edaravone is an antioxidant drug approved for use in stroke and ALS, but edaravone does not cross the blood brain barrier effectively",Pass,CC1=NN(C(=O)C1)C2=CC=CC=C2,Edaravone,0
6854033,https://doi.org/10.3389/fneur.2019.01168,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Since cholesterol does not cross the blood–brain barrier (BBB), to ensure steady-state turnover, cholesterol synthesis is matched by its metabolism to 24S-hydroxycholesterol (24-OHC), which crosses the BBB and is delivered to peripheral organs and hence constitutes an intrinsic mechanism to prevent cholesterol accumulation in the brain",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
6868802,https://doi.org/10.1186/s40360-019-0367-x,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Preclinical evidence suggests that the agent does not cross the blood–brain barrier (BBB) to a significant extent [15, 26]",Fail,-,,
6872511,https://doi.org/10.1007/s12028-019-00749-w,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, We are aware of the fact that phenylephrine does not cross the blood–brain barrier,Pass,CNC[C@@H](C1=CC(=CC=C1)O)O,phenylephrine,0
6931095,https://doi.org/10.1016/j.omtm.2019.11.013,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"13,14 However, when delivered peripherally, GDNF does not cross the blood-brain barrier (BBB), posing a substantial technical challenge for therapeutic application",Duplicate,-,GDNF,0
6958331,https://doi.org/10.3390/ph12040144,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," This may represent a situation where the blood–brain barrier is “leaky”, as shown when the iron chelator deferoxamine, which does not cross the blood–brain barrier, is effective at reducing brain damage and symptoms",Pass,-,iron chelator deferoxamine,0
6958331,https://doi.org/10.3390/ph12040144,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Unfortunately, the full significance of protection by HPX in these studies is not yet clear because deferoxamine does not cross the blood–brain barrier",Pass,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,deferoxamine,0
6963688,https://doi.org/10.3390/diagnostics9040226,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," More importantly, ERT provides limited or no impact on skeletal and neurological manifestations of MPS, most likely due to its limited permeability to avascular cartilage and its inability to cross the blood–brain barrier, respectively [12]",Duplicate,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
6976301,https://doi.org/10.1126/sciadv.aax6646,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," The therapeutic efficacy of NGF is limited by its short half-life, detrimental effects related to p75NTR activation, and its inability to cross the blood-brain barrier (BBB) (5)",Pass,C([C@@H]([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)NC(=O)CO)O)C(=O)C(=O)O,NGF,0
7009406,https://doi.org/10.2903/j.efsa.2018.5243,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Though the brain is its primary site of action, morphine does not cross the blood‐brain barrier easily",Fail,-,,
7016658,https://doi.org/10.3390/cancers12010245,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Treatment for glioblastoma is inadequate; most chemotherapeutics are unable to cross the blood–brain barrier to reach tumor sites, and successfully removing all surrounding tumor cells by surgical resection is difficult [3]",Fail,-,,
7019666,https://doi.org/10.3390/nu12010079,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"As mentioned above, serotonin is unable to cross the blood-brain barrier",Pass,C1=CC2=C(C=C1O)C(=CN2)CCN,serotonin,0
7022483,https://doi.org/10.3390/antiox9010024,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Conventional antioxidant therapies have been used for a long time but unfortunately have proved less effective for many reasons, including their inability to cross the blood–brain barrier, which in turn has rendered them ineffective in many neurodegenerative diseases [35]",Fail,-,,
7035786,https://doi.org/10.1186/s12974-020-01746-z,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Infliximab is an anti-TNF-a antibody that does not cross the blood-brain barrier [40], binds to peripheral TNF-a, and reduces peripheral inflammation in rats with MHE or hyperammonemia [9, 10, 22]",Pass,-,Infliximab,0
7097701,https://doi.org/10.1001/jamanetworkopen.2020.1617,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*,"4,5 Targeted therapies have been proposed to fill this gap, despite historical concerns that the benefit of systemic therapies as treatments for IMD has been limited by their inability to penetrate the blood-brain barrier (BBB)",Fail,-,,
7139651,https://doi.org/10.3390/ijms21062010,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Initially, the opinion was that ADPN was initially thought not to be present in the brain, and not detectable in CSF [12,13], probably because of its inability to cross the blood-brain barrier (BBB)",Pass,-,ADPN,0
7174042,https://doi.org/10.1093/brain/awz382,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, as peripheral circulating cholesterol does not cross the blood–brain barrier, the brain must synthesize its own cholesterol",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
7197847,https://doi.org/10.4103/psychiatry.IndianJPsychiatry_37_19,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"Typically, under normal conditions, contrast agent does not cross the blood–brain barrier (BBB), when the integrity of the BBB is disrupted, and contrast agent permeates the CNS, subsequently causing injury by direct neuronal toxicity, patients may show delirium",Fail,-,,
7235994,https://doi.org/10.3390/biology9040079,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," The mentioned compounds studied for targeting CSCs can also be tested against Acanthamoeba for their effects on the process of differentiation and dedifferentiation, as currently there is no single method of treatment for Acanthamoeba infections due to resistant cysts forms and inability to cross the blood brain barrier in case of AK and AGE, respectively [94]",Fail,-,,
7247521,https://doi.org/10.1016/j.biopha.2020.110281,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*, Only compound W5 and W11 were entirely unable to penetrate the blood-brain barrier (BBB) and central nervous system (CNS),Fail,-,,
7279295,https://doi.org/10.3390/ijms21103623,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Supporting this hypothesis, previous studies [41,42] have shown that morphine withdrawal syndrome induced by naloxone methyl methiodide (quaternary derivative of naloxone that does not cross the blood–brain barrier) produces cardiac noradrenergic hyperactivity and increased c-Fos expression in different cardiac tissues, similarly to the cardiac changes observed after naloxone administration",Pass,-,naloxone methyl methiodide,0
7289103,https://doi.org/10.1016/j.lfs.2020.117963,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"4 software [19]:•Stars (similarity to known drugs): 0–2 (high), 3 (medium) e > 4 (low);•%Human Oral Absorption (%HOA): >80% (high), 25–80% (medium) e < 25% (low);•pCaco (intestinal cells): >500 nm/s (good) e < 25 nm/s (low);•pMDCK (kidney cells): >500 nm/s (good) e < 25 nm/s (low);•logKhsa (binding to human serum albumin): −1,5 (low) a 1,5 (high);•CNS: −2 (low permeability) e > −2 (high permeability);•logBB (blood/brain barrier): <−1 (low) e > −1 (easy permeation);•PSA (Van der Waals surface area): >60 (does not cross the blood/brain barrier) e < 60 (to cross the blood/brain barrier)",Fail,-,,
7290510,https://doi.org/10.3390/toxins12050291,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"However, being unable to cross the blood–brain barrier (BBB), CNF1 requires an intracerebral injection, as evidenced in all studies so far conducted using CNF1 on mouse models for CNS pathologies, including Rett syndrome (RTT) [5,6,7], Alzheimer’s disease [8], epilepsy [9] as well as GBM [4,10,11]",Pass,-,CNF1,0
7295786,https://doi.org/10.1038/s41467-020-16832-2,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*," Systemic treatments, such as chemotherapies or targeted therapies, cannot effectively treat micrometastatic brain lesions or prevent brain metastatic relapse, largely due to their inability to penetrate the blood–brain barrier (BBB)1",Fail,-,,
7306895,https://doi.org/10.3233/JAD-190848,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As Imatinib does not cross the blood-brain barrier (BBB), this provided evidence that Aβ produced peripherally was contributing to brain Aβ",Duplicate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Imatinib,0
7319894,https://doi.org/10.1111/nmo.13833,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Astressin, a CRF1/2 receptor antagonist that does not cross the blood–brain barrier (Tocris [Cat",Pass,CCCC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)CC2=CNC=N2)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@@H](CC4=CC=CC=C4)N,Astressin,0
7327654,https://doi.org/10.3324/haematol.2020.248518,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"Drug therapies successfully employed in MM might be ineffective in CNS-MM due to: tumor resistance after previous therapy,8 because they require interaction with the BM microenvironment,47 or the inability to cross the blood-brain barrier (BBB)",Fail,-,,
7374656,https://doi.org/10.1038/s41583-020-0333-z,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, CBX does not cross the blood–brain barrier91 and is therefore likely to act largely in the periphery, and gap junction blockers did not affect the withdrawal threshold in control mice",Pass,-,CBX,0
7384432,https://doi.org/10.1016/j.ejmech.2020.112652,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Chromatographic tests showed that analogues 162h and 162i with C10 and C12 alkyl chain, respectively lack anticonvulsant effect due to the inability to cross the blood brain barrier (BBB)",Fail,-,,
7388140,https://doi.org/10.3892/etm.2020.8789,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Under normal circumstances, the brain does not express IgE receptor (FcεRI), since the brain does not display any allergic reactions and IgE does not cross the blood-brain barrier (BBB) under normal conditions (55)",Pass,CC(C)OCC1CO1,IgE,0
7393986,https://doi.org/10.1016/j.heliyon.2020.e04557,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Methylscopolamine (1 mg/kg in rats) is also given to the animals 30 min before pilocarpine administration to reduce any peripheral effects caused by pilocarpine, which unlike scopolamine, does not cross the blood brain barrier (BBB) (Davis and Berger, 2013)",Pass,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,pilocarpine,0
7414904,https://doi.org/10.1038/s41598-020-70290-w,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," HPβCD does not cross the blood–brain barrier (BBB)5, and HPβCD administration to NPC1 patients uses intrathecal administration via injections into the lumbar cerebrospinal fluid (CSF)6",Pass,-,HPbetaCD,0
7461213,https://doi.org/10.3390/ijms21165732,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Up to now, almost all therapeutic approaches have been hindered by an inability to cross the blood-brain barrier (BBB) without invasive administration (intrathecal (IT) or intracerebroventricular (ICV))",Fail,-,,
7489857,https://doi.org/10.1001/jamanetworkopen.2020.15444,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,Cytotoxic chemotherapy has shown limited activity in the nervous system due to its inability to cross the blood-brain barrier (BBB),Fail,-,,
7503657,https://doi.org/10.3390/ijms21176336,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Peripheral apoE does not cross the blood–brain barrier (BBB), resulting in two separate pools of apoE, one in the periphery and one in the CNS",Fail,-,,
7527439,https://doi.org/10.3389/fnins.2020.00923,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"It is worth mentioning that GABA has long been thought to be unable to cross the blood–brain barrier (BBB) (Kuriyama and Sze, 1971; Roberts, 1974), which raises questions about the mechanisms of action behind its health benefits",Duplicate,C(CC(=O)O)CN,GABA,0
7540463,https://doi.org/10.1002/chem.202002067,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, It has potential as biotherapeutic agent but its application is dramatically hindered by rapid metabolism/degradation and low bioavailability after administration because the pentapeptide itself is unable to cross the blood–brain barrier (BBB),Fail,-,,
7558676,https://doi.org/10.3390/tropicalmed5030138,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Evidence of IgM in CSF is the cornerstone of the WNV diagnosis because IgM does not cross the blood brain barrier,Pass,C1CN(CC2=C1C(=C(S2)NC(=O)C3=CC(=C(C=C3Cl)Cl)S(=O)(=O)N4CCOCC4)C#N)CC5=CC=C(C=C5)O,IgM,0
7562719,https://doi.org/10.1038/s41598-020-74346-9,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," According to a Phase III trial (ENDEAR), nusinersen showed moderate therapeutic effects with delayed disease progression and ventilation timing9, but was unable to penetrate the blood–brain barrier (BBB)",Pass,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=S)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OC[C@@H]8[C@H]([C@H]([C@@H](O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,nusinersen,0
7564414,https://doi.org/10.3390/cancers12092682,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,", NY-3460, NY-3238, Spantide I and II) show poor potency, neurotoxicity, a poor ability to discriminate between tachykinin receptors, an inability to cross the blood–brain barrier and metabolic instability, and for these reasons, the use of them in clinical practice is very limited [2,3]",Pass,CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)CC6=CC=C(C=C6)O,NY-3238,0
7564414,https://doi.org/10.3390/cancers12092682,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,", NY-3460, NY-3238, Spantide I and II) show poor potency, neurotoxicity, a poor ability to discriminate between tachykinin receptors, an inability to cross the blood–brain barrier and metabolic instability, and for these reasons, the use of them in clinical practice is very limited [2,3]",Pass,CC(C)C[C@@H](CN[C@@H](CC(C)C)C(=O)N)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@@H](CC6=CC=CC=C6)NC,NY-3460,0
7564414,https://doi.org/10.3390/cancers12092682,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,", NY-3460, NY-3238, Spantide I and II) show poor potency, neurotoxicity, a poor ability to discriminate between tachykinin receptors, an inability to cross the blood–brain barrier and metabolic instability, and for these reasons, the use of them in clinical practice is very limited [2,3]",Pass,CC(C)C[C@@H](C(=O)N)NC(=O)C(CC(C)C)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)C6CCCN6C(=O)[C@H](CCCCN)NC(=O)C7CCCN7C(=O)[C@@H](CCCN=C(N)N)N,Spantide I,0
7564414,https://doi.org/10.3390/cancers12092682,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,", NY-3460, NY-3238, Spantide I and II) show poor potency, neurotoxicity, a poor ability to discriminate between tachykinin receptors, an inability to cross the blood–brain barrier and metabolic instability, and for these reasons, the use of them in clinical practice is very limited [2,3]",Pass,CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)C2=CN=CC=C2)N)C(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CN=CC=C4)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@@H](CC8=CNC9=CC=CC=C98)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC1=CC(=C(C=C1)Cl)Cl)N,Spantide II,0
7569317,https://doi.org/10.2174/1570159X18666200128121920,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," However, imatinib does not cross the blood-brain barrier effectively and is also readily effluxed by P-glycoprotein",Pass,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,imatinib,0
7589203,https://doi.org/10.3390/ijms21207452,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,Glutamate is a nonessential amino acid that does not cross the blood–brain barrier and is extensively distributed throughout the CNS,Pass,C(CC(=O)[O-])C(C(=O)[O-])[NH3+],Glutamate,0
7602430,https://doi.org/10.3390/pharmaceutics12100970,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*," Oligonucleotides have shown potential use in neurodegenerative diseases such as Alzheimer’s and Parkinson’s; however, their applications in the treatment of these diseases are hindered by their instability against metabolism, their inability to penetrate the blood–brain barrier, and their rapid clearance by renal excretion",Pass,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1CO)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O,Oligonucleotides,0
7609867,https://doi.org/10.3389/fonc.2020.563938,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*," Many drugs cannot be used in patients with glioma because of their poor physicochemical properties, lack of targeting capability, and their inability to penetrate the blood–brain barrier (BBB) and blood−brain tumor barrier (BBTB) (8–10)",Fail,-,,
7647061,https://doi.org/10.1371/journal.pone.0241773,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, there are many drawbacks for such strategies including (1) the large size of monoclonal antibodies, (2) requirement of large doses for effective treatment and (3) their inability to cross the blood-brain barrier (BBB) [5]",Fail,-,,
7647061,https://doi.org/10.1371/journal.pone.0241773,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, The large size of antibodies often makes them unable to cross the blood-brain barrier (BBB) limiting their widespread usage,Fail,-,,
7650135,https://doi.org/10.1186/s42466-019-0026-0,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*,"BBB Blood brain barrier, MS Multiple sclerosis, OPC Oligodendroglial precursor cell, PTH Parathyroid hormone, MOG Myelin oligodendrocyte glycoprotein, PLP Proteolipid protein, EAE Experimental autoimmune encephalomyelitis, NMO Neuromyelitis optica, MP4 MBP-PLP fusion protein, NOD Non-obese diabetes, OTC Over the counter, + = penetrates the blood brain barrier, (+) = only little evidence for BBB penetration or low permeability, − = does not penetrate the blood brain barrier, * = Anti-NogoA antibody was administered intravenously in clinical trials with MS patients, but pharmacokinetic data was not publicly accessibleFig",Fail,-,,
7671941,https://doi.org/10.1016/j.cmet.2020.04.013,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," PEGyAMPH does not cross the blood-brain barrier (BBB), yet retains the capacity to facilitate activation of sympathetic neurons and to increase peripheral NE availability in adipose tissues",Pass,-,PEGyAMPH,0
7693420,https://doi.org/10.3390/cancers12113232,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"3 nM), and does not cross the blood-brain barrier [144,145]",Fail,-,,
7696907,https://doi.org/10.3390/ijms21228651,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," However, these molecules are relatively large and typically unable to cross the blood–brain barrier, thus hindering their usefulness as therapeutics",Fail,-,,
7701684,https://doi.org/10.2147/DDDT.S271952,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*," Since the brain is not the target location in this study, it is desirable that the experimental compound does not penetrate the blood-brain barrier (BBB) to diminish any possible disturbances to the brain homeostasis",Fail,-,,
7724090,https://doi.org/10.3389/fonc.2020.574011,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Here, the PROTAC RC-32 rendered FKBP12 undetectable after only one day in most organs except the brain, indicating its inability to cross the blood-brain barrier",Fail,-,,
7725667,https://doi.org/10.1016/j.omtm.2020.10.016,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"5 Nonetheless, ERT presents significant limitations for long-term treatment of FD, such as low half-life and biodistribution, activation of the immune system, the inability to cross the blood brain barrier (BBB), and the mode of administration",Duplicate,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
7735756,https://doi.org/10.7554/eLife.60648,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Hoechst is unable to cross the blood-brain barrier and therefore will label circulating monocytes but will not label brain resident macrophages (Cambier et al,Pass,-,Hoechst,0
7745688,https://doi.org/10.1136/jitc-2020-001511,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,23 24 51 56 It remains to be determined whether targeting IL-6R in isolation during established CRS is insufficient to prevent subsequent neurotoxicity or if the lack of efficacy is due to tocilizumab’s inability to cross the blood–brain barrier,Fail,-,,
7749467,https://doi.org/10.4103/1673-5374.284976,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"Typically, HIV is unable to cross the blood-brain barrier alone",Pass,-,HIV,0
7758909,https://doi.org/10.1093/noajnl/vdaa119,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," To determine the localization of [18F]PARPi in the brain, we compared its distribution to that of FITC–Dextran (Life Technologies, ThermoFisher Scientific), which does not cross the blood–brain barrier",Pass,-,FITC–Dextran,0
7760788,https://doi.org/10.3390/jcm9123793,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," It does not cross the blood-brain barrier, but it is synthetized and recycled locally in the brain, mainly by oligodendrocytes [313]",Fail,-,,
7795367,https://doi.org/10.3390/ijms22010196,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, (2) Most of the developed nanoparticles do not have long blood residence time that is why a large portion of them accumulate in the liver and spleen and unable to cross the blood-brain barrier,Fail,-,,
7818087,https://doi.org/10.1002/acn3.51254,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," The challenge of addressing CNS changes with ERT is also seen with mucopolysaccharidosis II, an LSD for which IV idursulfase improves somatic signs and symptoms of the disease, but does not cross the blood–brain barrier in therapeutic quantities and cannot mitigate CNS aspects of the disease",Pass,-,mucopolysaccharidosis II,0
7822063,https://doi.org/10.1080/14756366.2020.1847100,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Compounds 4g and 4h are predicted by the SwissADME to be unable to cross the blood–brain barrier15,Fail,-,,
7828547,https://doi.org/10.3390/biomedicines9010074,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," However, boron-containing AuNPs may have limited clinical potential for brain tumors because they are unable to penetrate the blood–brain barrier (BBB) adequately, and they may be trapped in filtrating organs [20]",Fail,-,,
7862291,https://doi.org/10.1038/s42003-021-01666-5,pmc,blood brain barrier permeability,.*unable to penetrate the blood.brain barrier.*," Furthermore, current KMO inhibitors possess a carboxylic acid group and are thought to be unable to penetrate the blood-brain barrier18,23,25",Fail,-,,
7866791,https://doi.org/10.3390/jcm10030493,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," The prokinetic dopamine receptor antagonist domperidone is possibly useful for treatment of nausea and delayed gastric emptying in PD, since it does not cross the blood-brain barrier in contrast to metoclopramide [124]",Fail,-,,
7890370,https://doi.org/10.1016/j.esmoop.2021.100057,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"Diffusion restriction of systemic agents into the central nervous system was considered a potential obstacle for clinically meaningful intracranial efficacy of immune checkpoint inhibitors, which are unable to cross the blood–brain barrier due to their large molecular weight",Fail,-,,
7911285,https://doi.org/10.3390/nano11020278,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," However, this is a less efficient treatment since these are unable to cross the blood–brain barrier [221]",Fail,-,,
7912729,https://doi.org/10.3390/biomedicines9020139,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, The renal spill-over of dopamine into the circulation with salt loading [104] does not extend into the brain because dopamine does not cross the blood–brain barrier [122],Fail,-,,
7913790,https://doi.org/10.3390/pharmaceutics13020212,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," These challenges include a risk of drug degradation and clearance by the rest of the body, intolerable systemic toxicity, and inability to cross the blood–brain barrier (BBB) at the tumor site [4]",Fail,-,,
7914730,https://doi.org/10.3390/molecules26040866,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, Our second strategy was to develop CB1 receptor antagonists that are unable to cross the blood brain barrier,Fail,-,,
7952171,https://doi.org/10.1155/2021/6613510,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,The main reason relating to the defective therapeutics in regard to ischemic stroke is that most drugs are unable to cross the blood-brain barrier (BBB) [4],Fail,-,,
7970566,https://doi.org/10.1021/acsomega.1c00030,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,does not cross the blood brain barrier,Fail,-,,
7980459,https://doi.org/10.1073/pnas.1907653118,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," An Evans blue permeability assay was used to measure blood–brain barrier integrity, Evans blue is an intravital dye that binds to albumin, which does not cross the blood–brain barrier under normal conditions (20)",Fail,-,,
8000199,https://doi.org/10.3390/cells10030541,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"Many cancer therapeutics are limited by their inability to cross the blood–brain barrier, limiting potential treatment options for brain cancers and metastases",Fail,-,,
8004823,https://doi.org/10.3390/jcm10061313,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As domperidone does not cross the blood–brain barrier, the risk of hyperprolactinemia and extrapyramidal symptoms is significantly lower in comparison with metoclopramide",Pass,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,domperidone,0
8015442,https://doi.org/10.17712/nsj.2018.4.20170391,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*,"18 Under normal physiological conditions, the serum NSE concentration is extremely low owing to its relatively large molecular weight and, hence, its inability to penetrate the blood-brain barrier and the cerebrospinal fluid-brain barrier",Fail,-,,
8033012,https://doi.org/10.3389/fphar.2021.612692,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, The major reason is not the activity of the respective drug(s) but being unable to cross the blood-brain barrier (BBB),Fail,-,,
8036872,https://doi.org/10.3390/ijms22073661,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Since the major side effects of drugs like rimonabant were CNS related, one opportunity to move forward could be provided by CB1R antagonists that are unable to cross the blood–brain barrier [97]",Fail,-,,
8043919,https://doi.org/10.1007/s00401-020-02248-1,pmc,blood brain barrier permeability,.*inability to penetrate the blood.brain barrier.*," When given systemically, BDNF administration is hindered by its inability to penetrate the blood–brain barrier and its incredibly short half-life [30]",Pass,-,BDNF,0
8096522,https://doi.org/10.1016/S1474-4422(20)30412-9,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Third, there are some unique problems related to APOE separate peripheral (liver generated) and CNS pools and its inability to cross the blood-brain barrier",Fail,-,,
8102834,https://doi.org/10.3389/fnins.2021.653651,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Even though cholesterol does not cross the blood–brain barrier (BBB) in physiological conditions, cholesterol oxidized products like oxysterols can cross it and may play a role in memory consolidation and AD pathophysiology (Lutjohann et al",Duplicate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
8106282,https://doi.org/10.4103/ijpvm.IJPVM_278_19,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Orally administered GABA is safe for humans, and acts on peripheral GABA receptors but does not affect CNS functions, since it does not cross the blood-brain barrier (BBB)",Duplicate,C(CC(=O)O)CN,GABA,0
8112934,https://doi.org/10.1155/2021/8874503,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,KA does not cross the blood-brain barrier easily under normal conditions and does not have a significant effect on the central nervous system [47],Pass,-,KA,0
8115123,https://doi.org/10.3389/fmolb.2021.643681,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"Counterintuitively, many of the advanced NBTs, both approved for clinical use and under development, are intended for the treatment of neurological disorders despite difficulties in delivering NBTs to the CNS that result from their inability to cross the blood–brain barrier (BBB)",Fail,-,,
8116309,https://doi.org/10.1016/j.immuni.2021.04.007,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," When 6-OHDA is injected to the periphery, it does not cross the blood-brain barrier (BBB; Kostrzewa and Jacobowitz, 1974)",Duplicate,C1=C(C(=CC(=C1O)O)O)CCN,6-OHDA,0
8123663,https://doi.org/10.3390/ijms22094537,pmc,blood brain barrier permeability,.*inability to pass through the blood.brain barrier.*, The main limitation in the clinical use of GDNF and other neurotrophic proteins in the treatment of PD is their inability to pass through the blood–brain barrier (BBB),Pass,-,GDNF,0
8146593,https://doi.org/10.3390/ph14050409,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," It is a non-selective muscarinic receptor antagonist, less lipophilic than oxybutynin and does not cross the blood-brain barrier (BBB)",Fail,-,,
8147134,https://doi.org/10.3390/v13050811,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," However, these antibodies were unable to cross the blood–brain barrier thus preventing therapeutic efficacy on disease progression in the central nervous system",Fail,-,,
8147134,https://doi.org/10.3390/v13050811,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, One disadvantage of many of these compounds is their inability to cross the blood-brain barrier,Fail,-,,
8150869,https://doi.org/10.3390/nu13051591,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, The impact of GABA on the nervous system appears to be indirect—via the enteric nervous system—which allows to circumvent the question of GABA’s inability to cross the blood–brain barrier,Duplicate,C(CC(=O)O)CN,GABA,0
8151233,https://doi.org/10.3390/molecules26102834,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Similarly, following administration of a single 150 mg/kg dosage of trans-resveratrol-3-O-glucoside in rats, the digestive tract was found to be the major distribution tissue of resveratrol and its derivatives at 150 mg/kg dosage of, in contrast to which, resveratrol was found poorly distributed into the brain indicating their inability to cross the blood-brain barrier [51]",Fail,-,,
8151341,https://doi.org/10.3390/jof7050371,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Although exogenous GABA administration has long thought to be unable to cross the blood–brain barrier (BBB), studies have reported that the oral GABA administration can act on the peripheral nervous system of the digestive organs and improves the sleep behaviors [38,39]",Fail,-,,
8155219,https://doi.org/10.4162/nrp.2021.15.3.309,pmc,blood brain barrier permeability,.*unable to pass through the blood.brain barrier.*," It has been accepted that ingested GABA is unable to pass through the blood-brain barrier (BBB) [32], a semipermeable border formed by vessels, regulating the influx and efflux between the blood and the brain to protect neural tissue and function [33]",Duplicate,C(CC(=O)O)CN,GABA,0
8155678,https://doi.org/10.3389/fchem.2021.679776,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," This is also reflected in its inability to cross the blood-brain barrier, as pointed out by Levin (Levin and Ellingson, 2018), and this difficulty in reaching the primary site of action may well reduce the efficacy of the drug, and prevent it from accessing certain target tissues where diseases amenable to its actions are manifested",Fail,-,,
8155952,https://doi.org/10.3390/cells10051228,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Baclofen has poor liposolubility and does not cross the blood–brain barrier (BBB) efficiently [227], but it systemic administration reduced behavioral hyperactivity and/or prepulse inhibition deficits in animal models of schizophrenic psychoses induced by methamphetamine [228], MK-801 [229], or phencyclidine [230]",Pass,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Baclofen,0
8187781,https://doi.org/10.3389/fneur.2021.651639,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*, A major limitation of coenzyme Q10 is its inability to cross the blood–brain barrier when taken orally,Fail,-,,
8198206,https://doi.org/10.3390/molecules26113304,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," Their capability for targeting neuron and glial cells can help them overcome problems caused by traditional PAMAM dendrimers, which is their inability to cross the blood brain barrier (BBB)",Fail,-,,
8199538,https://doi.org/10.3390/ijms22115997,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"For a long time, the central nervous system (CNS) was considered as an immune-privileged tissue, isolated from peripheral immune cells unable to cross the blood–brain barrier (BBB) under normal conditions [4]",Fail,-,,
8231765,https://doi.org/10.3390/medicina57060616,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In addition, PROSPER used pravastatin, which does not cross the blood brain barrier and the statin doses were mostly not as high as current guidelines recommend [67]",Pass,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,pravastatin,0
8234992,https://doi.org/10.3390/ijms22126568,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Unfortunately, however, this drug does not cross the blood–brain barrier and therefore cannot activate the PPP in astrocytes in the brain",Fail,-,,
8268239,https://doi.org/10.3390/ijms22136737,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," The therapies available for the disease are associated with hindrances, such as inability to cross the blood–brain barrier (BBB), side effects, limited life span, etc",Fail,-,,
8272165,https://doi.org/10.3390/molecules26133963,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," Although TMZ is stable at acidic pH, under slightly alkaline conditions it is rapidly hydrolyzed to MTIC (5-(3-methyltriazen-1-yl) imidazole-4-carboxamide) which, although still active, is unable to cross the blood brain barrier and is rapidly metabolized to an inactive derivative [75]",Fail,-,,
8278877,https://doi.org/10.1039/d1sc02273c,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"34–37 However, as of now, there is just one example of this therapeutic approach being tested in vivo as many of these metal complexes are presumed to be either highly toxic or unable to cross the blood–brain barrier (BBB)",Fail,-,,
8281042,https://doi.org/10.3389/fimmu.2021.703972,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," GSH delivery to the CNS is difficult due to the inability to cross the blood-brain barrier, short half-life, and the requirement of high doses to achieve a therapeutic effect (154)",Pass,C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,GSH,0
8287815,https://doi.org/10.1186/s13020-021-00468-5,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*,"Paclitaxel does not penetrate the blood–brain barrier and could not accumulate in the central nervous system but will damage the peripheral nervous system, including nerve endings, peripheral nerves, and DRG",Pass,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Paclitaxel,0
8299985,https://doi.org/10.1016/j.prdoa.2020.100083,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Opicapone does not cross the blood–brain barrier (BBB) and inhibits only peripheral COMT enzymes [12], [13]",Pass,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],Opicapone,0
8304158,https://doi.org/10.3390/ijms22147387,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," We used piroxicam, which has no effect on wild-type mice, to accelerate/synchronize the development of colitis in IL-10-/- mice [31,32,33] and naloxone-methiodide, a general opioid receptor antagonist that does not cross the blood-brain barrier to neutralize opioid receptors in the periphery",Pass,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC=C.[I-],naloxone-methiodide,0
8304158,https://doi.org/10.3390/ijms22147387,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"In order to examine the impact of the mucosal opioid tone on the development of colitis, IL-10-/- mice fed with standard chow diet containing piroxicam were intraperitoneally injected over the 10 days of treatment with either PBS or naloxone-methiodide (NLX-methiodide), a general antagonist of opioid receptors unable to cross the blood-brain barrier, that has no pro-inflammatory effect per se in normal mice (Supplementary Figure S1)",Duplicate,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC=C.[I-],naloxone-methiodide,0
8305798,https://doi.org/10.3390/cancers13143474,pmc,blood brain barrier permeability,.*unable to pass through the blood.brain barrier.*," For example, cerebral metastases, also if hyper-expressing SSR, cannot be reached and destroyed by radiolabeled SSA, if the radiotracer is unable to pass through the blood–brain barrier (BBB)",Fail,-,,
8350061,https://doi.org/10.1016/j.jcmgh.2021.05.008,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*,"20 5-HT also is unable to cross the blood-brain barrier, thus lending spatial and functional separation based on where biosynthesis occurs",Pass,C1=CC2=C(C=C1O)C(=CN2)CCN,5-HT,0
8363105,https://doi.org/10.1016/j.jsps.2021.07.001,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*," However, the clinical effectiveness of CSP in GBM is reduced, owing to the inability to cross the blood–brain barrier, toxic side effects, drug resistance, and relapse",Duplicate,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,GBM,0
8375080,https://doi.org/10.1186/s40478-021-01240-4,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As DSS does not cross the blood–brain barrier, these effects were necessarily mediated by its activity in the periphery [78]",Pass,-,DSS,0
8379671,https://doi.org/10.1016/j.heliyon.2021.e07740,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,"ERT does not cross the blood-brain barrier (because of its large molecular size), or reverse skeletal changes, heart anomalies or corneal opacity (Sifuentes et al",Pass,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O,ERT,0
8391398,https://doi.org/10.3390/brainsci11080994,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Considering that PACAP does not cross the blood brain barrier, it could be helpful to synthetize new molecules targeting a peptide-driven signaling system to use in combination treatment with the existing therapeutic approach",Pass,-,PACAP,0
8392031,https://doi.org/10.3390/biom11081091,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, This is consistent with the notion that GABA is unable to cross the blood–brain barrier,Pass,C(CC(=O)O)CN,GABA,0
8392846,https://doi.org/10.3390/biomedicines9080926,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," In addition, recent pharmacokinetic data in mice suggest that semaglutide is unable to cross the blood-brain barrier (BBB) [16]",Pass,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC6=CN=CN6)N,semaglutide,0
8403007,https://doi.org/10.2147/JBM.S281247,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,"37 Regarding cytokine-directed therapy, tocilizumab is not usually recommended for treatment of neurotoxicity in the absence of concurrent CRS, because its inability to cross the blood-brain barrier and may paradoxically increase the concentration of IL-6 in the central nervous system",Pass,-,tocilizumab,0
8406754,https://doi.org/10.1186/s12888-021-03443-4,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Under normal conditions, CRP does not cross the blood-brain barrier",Pass,-,CRP,0
8438212,https://doi.org/10.3389/fmolb.2021.723003,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*, HIV-1 is usually unable to cross the blood-brain barrier (BBB),Pass,C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O,HIV-1,0
8439475,https://doi.org/10.1371/journal.pbio.3001358,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*, Sutcliffe showed that reducing presenilin-2 by administration of a cancer therapeutic that does not cross the blood–brain barrier reduced accumulation of Aβ in both blood and brain,Fail,-,,
8444436,https://doi.org/10.1186/s12974-021-02249-1,pmc,blood brain barrier permeability,.*does not penetrate the blood.brain barrier.*, AZA is absorbed rapidly through the GI system and does not penetrate the blood-brain barrier,Pass,-, AZA,0
8458799,https://doi.org/10.3389/fimmu.2021.700903,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," As 6-OHDA does not cross the blood–brain barrier (BBB), the peripheral administration of 6-OHDA does not affect the catecholamine levels in the CNS (15)",Pass,C1=C(C(=CC(=C1O)O)O)CCN, 6-OHDA,0
8486167,https://doi.org/10.1021/acs.jmedchem.1c00484,pmc,blood brain barrier permeability,.*inability to cross the blood.brain barrier.*,inability to cross the blood–brain barrier (BBB),Fail,-,,
8509516,https://doi.org/10.3390/ijms221910738,pmc,blood brain barrier permeability,.*unable to cross the blood.brain barrier.*," It has been suggested that OPCs are able to migrate within the CNS but not from the cerebrospinal fluid (CSF) or the blood, since they are unable to cross the blood-brain barrier; the route of access to demyelinated regions is therefore a relevant consideration in experimental protocols with these cells",Fail,-,,
8514700,https://doi.org/10.3389/fpsyt.2021.671151,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Pearson correlation analysis showed that HDRS-24 scores had no correlation with serum LC concentration, which may be because ~75% of human carnitine comes from exogenous sources (mainly from meat and dairy products), and L-carnitine does not cross the blood-brain barrier directly to exert antidepressant effects like acetyl-L-carnitine",Pass,C[N+](C)(C)C[C@@H](CC(=O)[O-])O,L-carnitine,0
8531270,https://doi.org/10.3389/fncel.2021.721376,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," Since cholesterol does not cross the blood-brain barrier, cholesterol must be made available to OLs autonomously by biosynthesis in OLs and by horizontal transfer from astrocytes (Camargo et al",Pass,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,0
8541353,https://doi.org/10.3390/molecules26206124,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*,5) does not cross the blood–brain barrier,Fail,-,,
8547687,https://doi.org/10.1371/journal.pone.0259044,pmc,blood brain barrier permeability,.*does not cross the blood.brain barrier.*," In general, ivermectin does not cross the blood-brain barrier in most animal species, including humans, and does not interact with peripheral neurotransmitters, making it safe enough for human use [15]",Pass,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,ivermectin,0
